{"id":"W4206303014","doi":"10.1007/s10549-021-06374-6","title":"Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population","year":2021,"lang":"en","type":"erratum","venue":"Breast Cancer Research and Treatment","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Letrozole; Breast cancer; Medicine; Oncology; Population; Cancer; Phase (matter); Internal medicine; Gynecology; Tamoxifen","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01123778,0.00304695,0.003128784,0.004443776,0.002653736,0.00471654,0.004640295,0.008246138,0.08269086],"category_scores_gemma":[0.1242566,0.002142863,0.00306021,0.003643961,0.002109876,0.002264393,0.001963316,0.01597902,0.04374271],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00599521,"about_ca_system_score_gemma":0.01003672,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03560466,"about_ca_topic_score_gemma":0.03960802,"domain_scores_codex":[0.9909382,0.00213418,0.001901429,0.001053931,0.003279834,0.000692373],"domain_scores_gemma":[0.9440569,0.02129343,0.003578813,0.003431546,0.02497899,0.002660368],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.00006438276,0.000005038924,0.00003683374,0.0001027795,0.00001670021,0.00004785675,0.000007375035,0.00002396573,0.000009318483,0.0001653824,0.9974319,0.002088441],"study_design_scores_gemma":[0.0005093918,0.00003781186,0.001002695,0.0007784779,0.0001393001,0.0003181384,0.00005408711,0.0002883674,0.0002059175,0.001602966,0.9950118,0.0000511452],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.00008464611,0.0006659783,0.0006387127,0.04963255,0.9414525,0.00005941698,0.005176194,0.00030555,0.001984557],"genre_scores_gemma":[0.008208992,0.007281286,0.01104692,0.2709771,0.4771434,0.001093955,0.01252343,0.004022638,0.2077023],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.08269086,"threshold_uncertainty_score":0.2766285,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.126157187733549,"score_gpt":0.4729401635544931,"score_spread":0.3467829758209441,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}